Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-04-26FDA Approved: FLUOROURACIL — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare’s original application for Fluorouracil as a generic injectable chemotherapy agent for multiple cancers.
-
CLINICAL_TRIALS trial_result · 2007-03-14Clinical Trial Update: A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy [Phase 2]
Phase 2 study of OSI-7904L in locally recurrent or metastatic head and neck cancer after failure of first-line therapy has completed.
-
CLINICAL_TRIALS trial_result · 2007-02-07Clinical Trial Update: Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery? [Phase 3]
Phase 3 trial assessing whether tranexamic acid reduces blood loss during head and neck surgery has been completed.
-
CLINICAL_TRIALS trial_result · 2007-01-15Clinical Trial Update: Safety and Efficacy of RK0202 in Oral Mucositis [Phase 2]
Phase 2 trial of RK0202 for oral mucositis reported safety and preliminary efficacy signals; the study has completed.
-
CLINICAL_TRIALS trial_result · 2006-12-07Clinical Trial Update: Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients [Phase 2]
A Phase 2 study investigates whether hypnosis can alleviate xerostomia after radiotherapy in head and neck cancer patients; the current tria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2006-05-12Clinical Trial Update: Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
This clinical trial update discusses using plasma circulating DNA as a biomarker to monitor treatment response in head and neck cancer and e…
-
CLINICAL_TRIALS trial_result · 2006-05-04Clinical Trial Update: Altered and Conventional Fractionated Radiotherapy in Patients With Head and Neck Cancer
Update on a completed clinical trial comparing altered and conventional fractionated radiotherapy in patients with head and neck cancer.